Maharashtra FDA targets overpriced medicines and tighter pharmacy compliance
Maharashtra’s FDA plans to flag potentially exorbitantly priced drugs to the National Pharmaceutical Pricing Authority while stepping up checks on hospital pharmacy restrictions, prescription-drug sales, manufacturing quality, food hygiene and packaging standards.
Maharashtra FDA plans to refer potentially exorbitantly priced medicines to NPPA, while tightening enforcement on hospital pharmacy restrictions, prescription-drug sales, manufacturing quality, food hygiene, packaging and beverage standards.
Why this matters
The action extends Maharashtra FDA's recent enforcement pattern, following food-safety crackdowns at restaurants, clubs and school zones and Mumbai club licence suspensions over hygiene breaches.
Retail-company signals are accelerating, up +254680% QoQ.